In one paragraphArticle in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
17 authors.
Sara Herráiz-GilDepartamento de Bioingeniería, Universidad Carlos III de Madrid, 28911 Leganés, Spain.ORCID 0000-0003-0682-5225 Alberto VarasImmunology Group, Health Research Institute of the Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.ORCID 0000-0001-8329-6457 Lidia M Fernández-SevillaImmunology Group, Health Research Institute of the Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.ORCID 0000-0003-0076-3254 Pilar ZuluagaDepartment of Statistics and Operations Research, Faculty of Medicine, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain.ORCID 0000-0002-1267-3021 Marcela Del RíoDepartamento de Bioingeniería, Universidad Carlos III de Madrid, 28911 Leganés, Spain.ORCID 0000-0003-2910-7189 Ángeles VicenteDepartment of Cell Biology and Histology, Faculty of Medicine, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain.ORCID 0000-0002-9456-5541 María J EscámezDepartamento de Bioingeniería, Universidad Carlos III de Madrid, 28911 Leganés, Spain.ORCID 0000-0002-5434-1885 Rosa SacedónImmunology Group, Health Research Institute of the Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.ORCID 0000-0002-7486-7120 Funding
DEBRA Austria, co-funded by DEBRA Sweden and EB-LOPPET Not applicableEB Research Network (León-1) Non applicableHULP-IdiPaz Dermatology Service and FIBHULP EC_5215HULP-IdiPaz Dermatology Service and FIBHULP I4V-MC-JAIPInstituto de Salud Carlos III, co-financed by the European Union through NextGenerationEU RICORS-TERAV RD21/0017/0010Instituto de Salud Carlos III, co-financed by the European Union through NextGenerationEU RICORS-TERAV RD21/0017/0033MCIN/AEI/10.13039/501100011033 PID2020-119792RB-I00MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe" PID2021-123068OB-I00
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Epidermolysis Bullosa DystrophicaNutritional StatusZincAdolescentAdultBiomarkersChildChild, PreschoolCross-Sectional StudiesDeficiency DiseasesFemaleHumansInfantInflammationMaleYoung AdultBiomarkersZincalbuminanemiainflammationrecessive dystrophic epidermolysis bullosaserum zinc levelsskin fragilityzinc deficiency
Identifiers
PMID41599845
PMCPMC12844941
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390